
Novel folate-caged pomalidomide-based anaplastic lymphoma киназы (ALK) PROTAC, effectively degrading ALK fusion proteins in cancer cells in a FOLR1-dependent manner
Novel folate-caged pomalidomide-based anaplastic lymphoma kinase (ALK) PROTAC, effectively degrading ALK fusion proteins in cancer cells in a FOLR1-dependent manner
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.